It seems as if hardly a week goes by now without reading about a new example of crowdsouricing or citizen scientists working on some of the most...

In our efforts to bring exposure to rare disease research through our Rare Disease Challenge, we’ve learned that only about 5% of the rare diseases...

Curing or even finding treatments for rare diseases is hard. Not necessarily because these diseases are any more complex than more common ones. It...

Scientist’s CEO, Kevin Lustig, spoke in a recent episode of the Burrill Report about the Open Science movement and how the democratization of drug...

Scientist is pleased to announce the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries). We are working...

In James Surowiecki’s book “The Wisdom of Crowds”, he lays out the criteria for successful decision making by large groups1: Diversity of opinion...

The Make Your Mark competition, part of Scientist’s Open Science Challenge series, is now officially live in San Diego, New York, and Boston...

For decades the model for how a clinical diagnostic assay (otherwise known as a clinical diagnostic, or a diagnostic test) was developed remained...

“Open source”, a term synonymous to computer programming, is a pragmatic methodology that promotes redistribution and access to an end product. In...

Yesterday we published in Scientific American’s blog a call to action about the Scientist-sponsored Rare Disease Science Challenge. If you or a...